E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway-Reference-Cited by-同舟云学术

E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway

Published:2022-07-18 Issue:4 Volume:30 Page:1229-1240
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod. Sci.

Author:

Huang Jiazhen,Zhao Ying^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

https://link.springer.com/content/pdf/10.1007/s43032-022-01034-6.pdf

Reference38 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

2. Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99.

3. Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human papilloma virus-associated cervical cancer and health disparities. Cells. 2019;8:6.

4. Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key molecular events in cervical cancer development. Medicina (Kaunas). 2019;55:7.

5. Wang X, Cao A, Hou Z, Li X, Gao B. Identification of key classification features of early cervical squamous cell carcinoma. Comput Biol Chem. 2021;93:107531.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA LINC01703 promotes the proliferation, migration, and invasion of colorectal cancer by activating PI3K/AKT pathway;Journal of Biochemical and Molecular Toxicology;2023-12-04

2. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification;Aging;2023-09-27

3. Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape;Oncology Research;2023